| scholarly article | Q13442814 |
| P50 | author | Silvano Adami | Q114314176 |
| P2093 | author name string | Paola Caramaschi | |
| Domenico Biasi | |||
| Ilaria Dal Forno | |||
| P2860 | cites work | Pathophysiology and natural history of avascular necrosis of bone | Q28259882 |
| Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus | Q33494659 | ||
| Osteonecrosis at multiple sites in a patient with systemic lupus erythematosus | Q33555633 | ||
| Early treatment of avascular necrosis in systemic lupus erythematosus | Q33556858 | ||
| Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity | Q33665237 | ||
| Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence | Q83932914 | ||
| Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI | Q84531557 | ||
| Extracorporeal shockwave for hip necrosis in systemic lupus erythematosus | Q84569801 | ||
| Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head | Q34127322 | ||
| Bone involvement in sickle cell disease. | Q34416473 | ||
| Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus | Q35013137 | ||
| Osteonecrosis in patients with SLE. | Q35148600 | ||
| Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? | Q35549358 | ||
| Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment | Q35549979 | ||
| Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study | Q35637240 | ||
| Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus | Q36611056 | ||
| Treatment of femoral head osteonecrosis in patients with systemic lupus erythematosus by free vascularised fibular grafting | Q37599181 | ||
| Osteoporosis in patients with systemic lupus erythematosus. | Q37627825 | ||
| The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review | Q37789109 | ||
| Atraumatic osteonecrosis of the distal radius and ulna: case series and review | Q37953185 | ||
| Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation. | Q38669038 | ||
| Extracorporeal shockwave treatment of osteonecrosis of the femoral head in systemic lupus erythematosis | Q39346564 | ||
| Avascular necrosis in systemic lupus erythematosus. Silent symmetric osteonecroses | Q40717117 | ||
| Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists | Q40816289 | ||
| Osteonecrosis after renal transplantation in children | Q41097078 | ||
| Atraumatic osteonecrosis of the talus | Q41752138 | ||
| High-Dose Intravenous Methylprednisolone Therapy Associated with Osteonecrosis in Patients with Systemic Lupus Erythematosus | Q41832446 | ||
| Primary total hip arthroplasty in systemic lupus erythematosus | Q41886464 | ||
| Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus | Q42229554 | ||
| Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan | Q43112509 | ||
| Factors associated with osteonecrosis in Thai lupus patients: a case control study. | Q43222206 | ||
| An analysis of joint replacement in patients with systemic lupus erythematosus | Q43256481 | ||
| Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus | Q43265889 | ||
| Hypofibrinolysis, thrombophilia, osteonecrosis | Q43603903 | ||
| Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies. | Q44229543 | ||
| Procoagulants and osteonecrosis | Q44388099 | ||
| ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation | Q44635593 | ||
| Avascular necrosis in systemic lupus erythematosus: clinical associations and a 47-year perspective. | Q44963739 | ||
| Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. | Q44972415 | ||
| Atherogenic high-fat diet reduces bone mineralization in mice | Q46289468 | ||
| The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study | Q46735132 | ||
| MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus. | Q46795653 | ||
| Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. | Q50978565 | ||
| Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. | Q51422493 | ||
| Long-term outcome of transtrochanteric anterior rotational osteotomy for osteonecrosis of the femoral head in patients with systemic lupus erythematosus. | Q51853950 | ||
| Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus. | Q52168843 | ||
| Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus | Q61974552 | ||
| Imaging study on the mode of development and changes in avascular necrosis of the femoral head in systemic lupus erythematosus: long-term observations. | Q64967883 | ||
| Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy | Q67324402 | ||
| Clinical research on intraosseous pressure in the upper femoral metaphysis and epiphysis in humans. Application to the diagnosis of ischemia and necrosis | Q69418693 | ||
| Magnetic resonance imaging of the ischemic hip. Alterations within the osteonecrotic, viable, and reactive zones | Q69649283 | ||
| Treatment of avascular necrosis of the femoral head | Q71198479 | ||
| Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation? | Q71683355 | ||
| Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies | Q72046815 | ||
| Risk factors for osteonecrosis in systemic lupus erythematosus | Q73218948 | ||
| Total knee arthroplasty for corticosteroid associated avascular necrosis of the knee | Q73384588 | ||
| Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus | Q73815983 | ||
| Damage in systemic lupus erythematosus and its association with corticosteroids | Q74175875 | ||
| Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus | Q74828195 | ||
| Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction | Q75288496 | ||
| Shock wave treatment shows dose-dependent enhancement of bone mass and bone strength after fracture of the femur | Q75363760 | ||
| Risk factors for avascular bone necrosis in systemic lupus erythematosus | Q77291745 | ||
| Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging | Q77993328 | ||
| The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head | Q78300258 | ||
| Shock wave therapy induces neovascularization at the tendon–bone junction. A study in rabbits | Q79156404 | ||
| Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant | Q79869720 | ||
| The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients | Q80153355 | ||
| Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study | Q82692992 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| lupus erythematosus | Q188297 | ||
| P304 | page(s) | 725249 | |
| P577 | publication date | 2012-08-05 | |
| P1433 | published in | Autoimmune Diseases | Q26842451 |
| P1476 | title | Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication | |
| P478 | volume | 2012 |
| Q38679869 | Assessment of condyle, masseter and temporal muscles volumes in patients with juvenile systemic lupus erythematosus: A cross-sectional study. |
| Q24564449 | Management issues with exogenous steroid therapy |
| Q90291221 | Multifocal osteonecrosis affecting all four limbs in systemic lupus erythematosus: A case report |
| Q88795359 | Prevalence and Associations of Avascular Necrosis of the Hip in a Large Well-characterized Cohort of Patients With Inflammatory Bowel Disease |
| Q41919918 | Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study |
Search more.